Yang P, Lei H, Fu Y, Chen C, Tang L, Xia S
Heliyon. 2024; 10(7):e29169.
PMID: 38633631
PMC: 11021977.
DOI: 10.1016/j.heliyon.2024.e29169.
Hashem M, Khosroshahi E, Aliahmady M, Ghanei M, Rezaie Y, Jafari Y
Noncoding RNA Res. 2024; 9(2):560-582.
PMID: 38515791
PMC: 10955558.
DOI: 10.1016/j.ncrna.2024.01.009.
Rencuzogullari O, Arisan E
Turk J Biol. 2023; 46(5):342-360.
PMID: 37529006
PMC: 10387936.
DOI: 10.55730/1300-0152.2622.
Hu Y, Li Q, Wang P, Li X, Hu Z
Front Oncol. 2023; 13:1140813.
PMID: 37182123
PMC: 10172652.
DOI: 10.3389/fonc.2023.1140813.
Iqbal M, Javed Z, Herrera-Bravo J, Sadia H, Anum F, Raza S
Cancer Cell Int. 2022; 22(1):354.
PMID: 36376956
PMC: 9664821.
DOI: 10.1186/s12935-022-02777-7.
Diagnostic Value of Prostate-Specific Antigen Combined with Plasma miRNA-149 Expression in Patients with Prostate Cancer Based on Experimental Data and Bioinformatics.
Wang H, Yang L, Mi Y, Wang Y, Ma C, Zhao J
Contrast Media Mol Imaging. 2022; 2022:6094409.
PMID: 35935308
PMC: 9337946.
DOI: 10.1155/2022/6094409.
Diagnosis value of miR-181, miR-652, and CA72-4 for gastric cancer.
Tian W, Pang X, Luan F
J Clin Lab Anal. 2022; 36(6):e24411.
PMID: 35446997
PMC: 9169223.
DOI: 10.1002/jcla.24411.
MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets.
Jorgensen B, Ro S
Int J Mol Sci. 2022; 23(4).
PMID: 35216281
PMC: 8876324.
DOI: 10.3390/ijms23042166.
MicroRNA: Crucial modulator in purinergic signalling involved diseases.
Guo J, Yang P, Li Y, Tang J, He Z, Yu S
Purinergic Signal. 2022; 19(1):329-341.
PMID: 35106737
PMC: 9984628.
DOI: 10.1007/s11302-022-09840-y.
MiR-200c-3p aggravates gastric cell carcinoma via KLF6.
Wang Y, Lu K, Li W, Wang Z, Ding J, Zhu Z
Genes Genomics. 2021; 43(11):1307-1316.
PMID: 34524611
PMC: 8478742.
DOI: 10.1007/s13258-021-01160-6.
Epigenetic Deregulation of Apoptosis in Cancers.
Ozyerli-Goknar E, Bagci-Onder T
Cancers (Basel). 2021; 13(13).
PMID: 34199020
PMC: 8267644.
DOI: 10.3390/cancers13133210.
Circulating miRNA 27a and miRNA150-5p; a noninvasive approach to endometrial carcinoma.
Ghazala R, El-Attar E, Abouzeid Z
Mol Biol Rep. 2021; 48(5):4351-4360.
PMID: 34076790
DOI: 10.1007/s11033-021-06450-6.
The Role of Snail-1 in Thyroid Cancer-What We Know So Far.
Wieczorek-Szukala K, Lewinski A
J Clin Med. 2021; 10(11).
PMID: 34073413
PMC: 8197874.
DOI: 10.3390/jcm10112324.
Dual activation of Hedgehog and Wnt/β-catenin signaling pathway caused by downregulation of SUFU targeted by miRNA-150 in human gastric cancer.
Peng Y, Zhang X, Lin H, Deng S, Qin Y, He J
Aging (Albany NY). 2021; 13(7):10749-10769.
PMID: 33848981
PMC: 8064165.
DOI: 10.18632/aging.202895.
The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas.
Artemaki P, Letsos P, Zoupa I, Katsaraki K, Karousi P, Papageorgiou S
Biomedicines. 2021; 9(4).
PMID: 33806113
PMC: 8064455.
DOI: 10.3390/biomedicines9040333.
Small RNAs as biomarkers to differentiate benign and malign prostate diseases: An alternative for transrectal punch biopsy of the prostate?.
Markert L, Holdmann J, Klinger C, Kaufmann M, Schork K, Turewicz M
PLoS One. 2021; 16(3):e0247930.
PMID: 33760831
PMC: 7990312.
DOI: 10.1371/journal.pone.0247930.
The association between circulating MicroRNA-150 level and cholangiocarcinoma.
El Sayed Salem P, Ghazala R, El Gendi A, Emara D, Ahmed N
J Clin Lab Anal. 2020; 34(11):e23397.
PMID: 33161598
PMC: 7676191.
DOI: 10.1002/jcla.23397.
MicroRNA-150 suppresses p27 expression and promotes cell proliferation in HeLa human cervical cancer cells.
Oboshi W, Hayashi K, Takeuchi H, Ikeda K, Yamaguchi Y, Kimura A
Oncol Lett. 2020; 20(5):210.
PMID: 32963616
PMC: 7491037.
DOI: 10.3892/ol.2020.12073.
MiR-940 promotes malignant progression of breast cancer by regulating FOXO3.
Zhang H, Peng J, Lai J, Liu H, Zhang Z, Li X
Biosci Rep. 2020; 40(9).
PMID: 32840296
PMC: 7494982.
DOI: 10.1042/BSR20201337.
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis.
Vita G, Aguennouz M, Polito F, Oteri R, Russo M, Gentile L
Front Mol Neurosci. 2020; 13:102.
PMID: 32655365
PMC: 7325132.
DOI: 10.3389/fnmol.2020.00102.